Shares of Gerresheimer AG (ETR:GXI – Get Free Report) fell 1.7% on Thursday . The stock traded as low as €76.65 ($83.32) and last traded at €79.70 ($86.63). 201,640 shares changed hands during trading, an increase of 43% from the average session volume of 140,925 shares. The stock had previously closed at €81.10 ($88.15).
Gerresheimer Price Performance
The stock has a market cap of $2.71 billion, a PE ratio of 23.34, a price-to-earnings-growth ratio of 0.82 and a beta of 0.94. The stock’s fifty day moving average is €91.46 and its 200-day moving average is €97.01. The company has a debt-to-equity ratio of 79.36, a current ratio of 0.87 and a quick ratio of 0.40.
Gerresheimer Company Profile
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Read More
- Five stocks we like better than Gerresheimer
- How to Calculate Options Profits
- Battle of the Retailers: Who Comes Out on Top?
- Election Stocks: How Elections Affect the Stock Market
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- How to Use High Beta Stocks to Maximize Your Investing Profits
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.